Table 3.
N | Group | Dystrophic pattern | Vacuoles | Inflammation | COX- | CD68/CD8/MHC-I | TDP-43/p62 |
---|---|---|---|---|---|---|---|
1 | IM-Mito | − | A | ++ | 3% | ++/++/+ | A/A |
2 | IM-Mito | + | A | ++ | 1% | ++/+/++ | P/A |
3 | IM-Mito | − | A | + | 1% | ++/+/+ | A/A |
4 | IM-Mito | + | A | ++ | 10% | ++/+/++ | A/A |
5 | IM-Mito | − | A | + | 1% | +/+/+ | A/A |
6 | IM-Mito | − | A | ++ | 1% | +/+/+ | A/P |
10 | IM-Mito | + | A | ++ | 1% | ++/+/++ | A/A |
16 | IM-Mito | − | A | + | 1% | +/+/+++ | A/A |
17 | IM-Mito | + | A | +++ | 1% | ++/++/+++ | A/P |
18 | IM-Mito | − | A | + | 1% | +/+/++ | A/A |
20 | IM-Mito | + | A | ++ | 2% | +/+/+++ | A/A |
22 | IM-Mito | + | A | ++ | 3% | ++/++/+++ | A/P |
23 | IM-Mito | + | A | + | 10% | +/+/+++ | A/A |
24 | IM-Mito | + | A | + | 5% | ++/+/++ | A/A |
7 | IBM | +++ | P | +++ | 10% | +++/+++/++ | P/P |
8 | IBM | + | P | ++ | 5% | ++/++/+++ | A/A |
9 | IBM | + | P | ++ | 1% | +++/+++/++ | P/P |
11 | IBM | ++ | P | + | 1% | +/+/+ | P/P |
12 | IBM | + | P | +++ | 2% | +++/+++/++ | A/P |
13 | IBM | ++ | P | ++ | 1% | ++/++/+++ | P/P |
14 | IBM | + | P | ++ | 1% | ++/++/++ | A/P |
15 | IBM | ++ | P | ++ | 5% | ++/++/+++ | P/P |
19 | IBM | + | P | ++ | 1% | ++/++/++ | A/A |
21 | IBM | + | P | ++ | 7% | ++/++/++ | A/A |
A, absent; P, present; −, no change; +, mild; ++, moderate; +++, severe.